Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells responsible for controlling voluntary muscle movement. Over time, the disease causes degeneration of motor neurons in the brain and spinal cord, leading to muscle weakness, loss of mobility, difficulty speaking and swallowing, and eventually respiratory complications.
Although several therapies exist to help slow disease progression and manage symptoms, researchers continue searching for approaches capable of supporting neuronal survival and improving long-term outcomes. In recent years, regenerative medicine has become an increasingly important area of ALS research, particularly involving mesenchymal stem cells (MSCs) and neural stem cell therapies.
In this review published in Frontiers in Neurology, researchers examined current and emerging therapeutic strategies for ALS, including the growing role of stem cell-based therapies and regenerative medicine approaches in neurological disease research.
Why Researchers Are Investigating Stem Cells in ALS
ALS is a complex disease involving inflammation, oxidative stress, mitochondrial dysfunction, and progressive degeneration of motor neurons. Because multiple biological pathways contribute to disease progression, researchers have become interested in therapies capable of influencing several mechanisms simultaneously.
According to the review, mesenchymal stem cells may offer therapeutic potential because of their anti-inflammatory, immunomodulatory, and neuroprotective properties. Rather than replacing damaged neurons directly, MSCs appear to support the nervous system by releasing signaling molecules, growth factors, and extracellular vesicles involved in cellular communication and tissue support.
Researchers discussed how MSCs may help:
- Regulate inflammatory activity
- Reduce harmful cytokine signaling
- Support neuronal survival
- Promote a more regenerative cellular environment
- Protect surrounding neural tissue from ongoing damage
These biological properties have made MSCs a major focus in regenerative medicine research for ALS and other neurodegenerative diseases.
Stem Cell Therapy and Neuroprotection
One of the major themes discussed in the review involves neuroprotection, or the ability to help preserve existing neurons and support nervous system function. Researchers noted that MSCs release several bioactive molecules that may help reduce inflammation and oxidative stress within the nervous system, both of which are strongly associated with ALS progression.
The review also highlighted growing interest in extracellular vesicles and exosomes derived from stem cells. These microscopic signaling particles may contribute to many of the therapeutic effects associated with regenerative medicine research by helping regulate cellular communication and inflammatory pathways.
Researchers believe stem cell-based therapies may help create a more supportive environment within damaged nervous tissue while promoting repair-related signaling mechanisms. Although these therapies remain under active investigation, early research continues to demonstrate encouraging potential in neurodegenerative disease studies.
Current Clinical Research in ALS
The review summarized several clinical studies involving stem cell therapies in ALS patients. According to the authors, many early-phase clinical trials have demonstrated favorable safety profiles and encouraging findings involving functional stabilization and supportive neurological effects following treatment.
Researchers emphasized that stem cell therapy continues to be explored alongside other emerging therapeutic strategies aimed at slowing disease progression and supporting motor neuron function. While additional large-scale clinical studies are still needed, regenerative medicine remains one of the most promising areas of ongoing ALS research.
The authors also noted that combining regenerative medicine approaches with advances in gene therapy, neuroprotective compounds, and anti-inflammatory treatments may help shape future therapeutic strategies for ALS management.
A Growing Area of Regenerative Medicine Research
This review highlights the expanding role of regenerative medicine in neurological disease research and the growing scientific interest surrounding mesenchymal stem cells in ALS. As researchers continue learning more about how stem cells interact with inflammation, neuronal survival pathways, and tissue repair mechanisms, stem cell-based therapies may become increasingly important in the future of neurodegenerative disease research.
Although further clinical investigation is still needed, MSC therapy and other regenerative medicine approaches continue to demonstrate encouraging potential because of their ability to support immune regulation, neuroprotection, and cellular repair processes simultaneously. The continued advancement of stem cell research may help open new possibilities for supporting patients living with ALS and other progressive neurological conditions.
Source
Mehta P, et al. Current potential therapeutics of amyotrophic lateral sclerosis. Front Neurol. 2024;15:1402962. doi: 10.3389/fneur.2024.1402962. Available from: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1402962/full